Dermata Therapeutics shares jump nearly 34% on positive topline results from cosmetic study

Dermata Therapeutics announced positive topline results from a cosmetic clinical study evaluating its recently launched skin renewal treatment, Tome Foundational Treatment. Following the announcement, the stock jumped nearly 34%.

Detected & updated continuously · Source: Nebula